This review focusses on recent relevant studies on fenofibrate in the treatment of dyslipidaemia. Key clinical studies discussed include 7 major studies and a Cochrane meta-analysis.
Independent commentary is provided by Professor Andrew Sindone, director of the Heart Failure Unit and Department of Cardiac Rehabilitation at Concord Hospital in Sydney.
Please login below to download this issue (PDF)